注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Virax Biolabs Group Ltd是一家生物技术公司。该公司主要从事用于病毒性疾病的预防、检测、诊断和风险管理的诊断检测试剂盒以及医疗技术和个人防护设备(PPE)产品的销售、分销和营销,特别关注以下领域免疫学。它正在开发一种T细胞测试技术,旨在提供一个免疫学分析平台,评估每个人针对全球病毒威胁的免疫风险状况。其产品组合包括:ViraxClear、ViraxCare和Virax Immune。ViraxClear提供一系列准确的诊断测试套件和机器。其产品包括抗原检测、聚合酶链反应(PCR)快速检测和中和抗体检测。ViraxCare在全球范围内开发和分销先进的医疗设备、技术和PPE。Virax Immune是一项新的Covid-19测试,旨在检测T细胞对SARS-Cov-2病毒的免疫反应。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Evan Norton | 48 | 2022 | Independent Director |
James Foster | 36 | 2022 | Chairman & CEO |
Yair Erez | 49 | 2022 | Independent Director |
Pierre Frouin | - | 2021 | Member of Advisory Board |
Nelson M. Haight | 58 | 2022 | Independent Director |
Nikolas Perrault | - | 2021 | Member of Advisory Board |
Bruce Lavin | - | 2021 | Member of Advisory Board |
Marc Frouin | - | 2021 | Member of Advisory Board |
Asaf Gol | - | 2021 | Member of Advisory Board |
Ian Noel Hampson | - | 2021 | Member of Advisory Board |
Mark James Ternouth | 55 | 2023 | Chief Technical Officer & Director |
Cameron Lee Shaw | 36 | 2022 | Member of Advisory Board |
Karen Bertoli | - | 2021 | Member of Advisory Board |
Peter Tijssen | - | 2021 | Member of Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核